Experimental pain ratings and reactivity of cortisol and soluble tumor necrosis Factor-α receptor II following a trial of hypnosis: Results of a randomized controlled pilot study

Pain Medicine

Volumn 13, Issue 1, 2012, Pages 29-44

  Goodin, Burel R ^a   Quinn, Noel B ^b   Kronfli, Tarek ^c   King, Christopher D ^a   Page, Gayle G ^d   Haythornthwaite, Jennifer A ^e   Edwards, Robert R ^f   Stapleton, Laura M ^b   Mcguire, Lynanne ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^c ALLIANT INTERNATIONAL UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF NURSING   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cortisol; HPA Axis; Hypnosis; Hypnotic Analgesia; Inflammation; Pain; Tumor Necrosis Factor

Indexed keywords

CYTOKINE; HYDROCORTISONE; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR II; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRY; ARTICLE; CLINICAL ARTICLE; COLD TOLERANCE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HYPNOSIS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; PAIN; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SALIVA ANALYSIS; TASK PERFORMANCE; TREATMENT OUTCOME;

EID: 84855718031     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2011.01293.x     Document Type: Article

References (77)

1. Montgomery GH, David D, Winkel G, Silverstein JH, Bovbjerg DH. The effectiveness of adjunctive hypnosis with surgical patients: A meta-analysis. Anesth Analg 2002;94:1639-45.
2. Montgomery GH, DuHamel KN, Redd WH. A meta-analysis of hypnotically induced analgesia: How effective is hypnosis? Int J Clin Exp Hypn 2000;48:138-53.
3. Schulz-Stubner S, Krings T, Meister IG, etal. Clinical hypnosis modulates functional magnetic resonance imaging signal intensities and pain perception in a thermal stimulation paradigm. Reg Anesth Pain Med 2004;29(6):549-56.
4. Berger MM, Davadant M, Marin C, etal. Impact of a pain protocol including hypnosis in major burns. Burns 2010;36:639-46.
5. Wiechman Askay S, Patterson DR, Jensen MP, Sharar SR. A randomized controlled trial of hypnosis for burn wound care. Rehabil Psychol 2007;52(3):247-53.
6. Wright BR, Drummond PD. Rapid induction analgesia for the alleviation of procedural pain during burn care. Burns 2000;26:275-82.
7. Abrahamsen R, Baad-Hansen L, Svensson P. Hypnosis in the management of persistent idiopathic orofacial pain: Clinical and psychosocial findings. Pain 2008;136(1-2):44-52.
8. Castel A, Perez M, Sala J, Padrol A, Rull M. Effect of hypnotic suggestion on fibromyalgia pain: Comparison between hypnosis and relaxation. Eur J Pain 2007;11:463-8.
9. Patterson DR, Jensen MP. Hypnosis and clinical pain. Psychol Bull 2003;129:495-521.
10. Jensen MP, Hanley MA, Engel JM, etal. Hypnotic analgesia for chronic pain in persons with disabilities: A case series. Int J Clin Exp Hypn 2005;53(2):198-228.
11. Price DD, Harkins SW, Baker C. Sensory-affective relationships among different types of clinical and experimental pain. Pain 1987;28:297-307.
12. Rainville P, Carrier B, Hofbauer RK, Bushnell MC, Duncan GH. Dissociation of sensory and affective dimensions of pain using hypnotic modulation. Pain 1999;82:159-71.
13. Rainville P, Hofbauer RK, Paus T, etal. Cerebral mechanisms of hypnotic induction and suggestion. J Cogn Neurosci 1999;11:110-25.
14. Price DD, Barber J. An analysis of factors that contribute to the efficacy of hypnotic analgesia. J Abnorm Psychol 1987;96:46-51.
15. Rainville P, Hofbauer RK, Bushnell MC, etal. Hypnosis modulates activity in brain structures involved in the regulation of consciousness. J Cogn Neurosci 2002;14:887-901.
16. Rainville P, Duncan GH, Price DD, Carrier B, Bushnell MC. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 1997;277:968-71.
17. Faymonville ME, Laureys S, Degueldre C, etal. Neural mechanisms of antinociceptive effects of hypnosis. Anesthesiology 2000;92(5):1257-67.
18. Jensen MP. The neurophysiology of pain perception and hypnotic analgesia: Implications for clinical practice. Am J Clin Hypn 2008;51:123-35.
19. Lang EV, Benotsch EG, Fick LJ, etal. Adjunctive non-pharmacological analgesia for invasive medical procedures: A randomized trial. Lancet 2000;355:1486-90.
20. De Jongh RF, Vissers KC, Meert TF, etal. The role of interleukin-6 in nociception and pain. Anesth Analg 2003;96(4):1096-103.
21. Hutchinson MR, La Vincente SF, Somogyi AA. In vitro opioid induced proliferation of peripheral blood immune cells correlates with in vivo cold pressor pain tolerance in humans: A biological marker of pain tolerance. Pain 2004;110(3):751-5.
22. McLean SA, Clauw DJ, Abelson JL, Liberzon I. The development of persistent pain and psychological morbidity after motor vehicle collision: Integrating the potential role of stress response systems into a biopsychosocial model. Psychosom Med 2005;67:783-90.
23. Sommer C, Kress M. Recent findings on how pro-inflammatory cytokines cause pain: Peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 2004;361(1-3):184-7.
24. Watkins LR, Maier SF, Goehler LE. Immune activation: The role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 1995;63:289-302.
25. Angst MS, Clark JD, Carvalho B, etal. Cytokine profile in human skin in response to experimental inflammation, noxious stimulation, and administration of a COX-inhibitor: A microdialysis study. Pain 2008;139(1):15-27.
26. Dixon KE, Thorn BE, Ward LC. An evaluation of sex differences in psychological and physiological responses to experimentally-induced pain: A path analytic description. Pain 2004;112:188-96.
27. Martinez V, Fletcher D, Bouhassira D, Sessler D, Chauvin M. The evolution of primary hyperalgesia in orthopedic surgery: Quantitative sensory testing and clinical evaluation before and after total knee arthroplasty. Anesth Analg 2007;105(3):815-21.
28. Cannon JG, Friedberg JS, Gelfand JA, etal. Circulating interleukin-1 beta and tumor necrosis factor-alpha concentrations after burn injury in humans. Crit Care Med 1992;20:1414-9.
29. Gauglitz GG, Song J, Herndon DN, etal. Characterization of the inflammatory response during acute and post-acute phases after severe burn. Shock 2008;30:503-7.
30. Hobson KG, Havel PJ, McMurtry AL, etal. Circulating leptin and cortisol after burn injury: Loss of diurnal pattern. J Burn Care Rehabil 2004;25(6):491-9.
31. Geiss A, Rohleder N, Kirschbaum C, etal. Predicting the failure of disc surgery by a hypofunctional HPA axis: Evidence from a prospective study on patients undergoing disc surgery. Pain 2005;114:104-17.
32. Johansson AC, Gunnarsson LG, Linton SJ, etal. Pain, disability and coping reflected in the diurnal cortisol variability in patients scheduled for lumbar disc surgery. Eur J Pain 2008;12(5):633-40.
33. Ohtori S, Inoue G, Ito T, etal. Tumor necrosis factor-immunoreactive cells and PGP 9.5-immunoreactive nerve fibers in verterbral endplates of patients with discogenic low back pain and modic type 1 or type 2 changes on MRI. Spine 2006;31(9):1026-31.
34. Costigan M, Scholz J, Woolf CJ. Neuropathic pain: A maladaptive response of the nervous system to damage. Annu Rev Neurosci 2009;32:1-32.
35. McBeth J, Silman AJ, Gupta A, etal. Moderation of psychosocial risk factors through dysfunction of the hypothamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain. Arthritis Rheum 2007;56(1):360-71.
36. Davidson RJ, Kabat-Zinn J, Schumacher J, etal. Alterations in brain and immune function produced by mindfulness meditation. Psychosom Med 2003;65:564-70.
37. Gruzelier JH. A review of the impact of hypnosis, relaxation, guided imagery and individual differences on aspects of immunity and health. Stress 2002;5:147-63.
38. Weber C, Arck P, Mazurek B, Klapp BF. Impact of a relaxation training on psychometric and immunological parameters in tinnitus sufferers. J Psychosom Res 2002;52:29-33.
39. Zautra AJ, Davis MC, Reich JW, etal. Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression. J Consult Clin Psychol 2008;76:408-21.
40. Shor RE, Orne EC. Harvard Group Scale of Hypnotic Susceptibility: Form A. Palo Alto, CA: Consulting Psychologists Press; 1962.
41. Weitzenhoffer AM, Hilgard ER. Stanford Hypnotic Susceptibility Scale: Form C. Palo Alto, CA: Consulting Psychologists Press; 1962.
42. Spiegel D, Bierre P, Rootenberg J. Hypnotic alteration of somatosensory perception. Am J Psychiatry 1989;146:749-54.
43. Kihlstrom JF, Register PA. Optimal scoring of amnesia on the Harvard Group Scale of Hypnotic Susceptibility, Form A. Int J Clin Exp Hypn 1984;32:51-7.
44. Shor RE, Orne MT, O'Connell DN. Validation and cross-validation of a scale of self-reported personal experiences which predicts hypnotizability. J Psychol 1962;53:55-75.
45. Appel PR, Bleiberg J. Pain reduction is related to hynotizability but not to relaxation or to reduction in suffering: A preliminary investigation. Am J Clin Hypn 2006;48(2-3):153-61.
46. Arendt-Nielsen L, Yarnitsky D. Experimental and clinical applications of quantitative sensory testing applied to skin, muscles and viscera. J Pain 2009;10(6):556-72.
47. Bisgaard T, Klarskov B, Rosenberg J, Kehlet H. Characteristics and prediction of early pain after laparoscopic cholecystectomy. Pain 2001;90:261-9.
48. Goodin BR, Quinn NB, King CD, etal. Salivary cortisol and soluble tumor necrosis factor-α receptor II responses to multiple experimental modalities of acute pain. Psychophysiology 2011; in press. doi: 10.1111/j.1469-8986.2011.01280.x.
49. Kirschbaum C, Hellhammer DH. Salivary cortisol in psychoneuroendocrine research: Recent developments and applications. Psychoneuroendocrinology 1994;19:313-33.
50. Lang EV, Lutgendorf S, Logan H, etal. Nonpharmacologic analgesia and anxiolysis for interventional radiological procedures. Semin Interv Radiol 1999;16:113-12.
51. Kiernan BD, Dane JR, Phillips LH, Price DD. Hypnotic analgesia reduces R-III nociceptive reflex: Further evidence concerning the multifactorial nature of hypnotic analgesia. Pain 1995;60:39-47.
52. Breivik H, Borchgrevnik PC, Allen SM, etal. Assessment of pain. Br J Anaesth 2008;101(1):17-24.
53. Dickerson SS, Kemeny ME, Aziz N, Kim KH, Fahey JL. Immunological effects of induced shame and guilt. Psychosom Med 2004;66:124-31.
54. Nishanian P, Aziz N, Chung J, Detels R, Fahey JL. Oral fluids as an alternative to serum for measurement of markers of immune activation. Clin Diagn Lab Immunol 1998;5:507-12.
55. Diez-Ruiz A, Tilz GP, Zangerle R, etal. Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995;54:1-8.
56. Kivlighan KT, Granger DA, Schwartz EB, etal. Quantifying blood leakage into the oral mucosa and its effects on the measurement of cortisol, dehydroepiandrosterone, and testosterone in saliva. Horm Behav 2004;46:39-46.
57. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
58. Dickerson SS, Kemeny ME. Acute stressors and cortisol responses: A theoretical integration and synthesis of laboratory research. Psychol Bull 2004;130:355-91.
59. Matheson G, Shue KL, Bart CA. Validation study of a short-form hypnotic experience questionnaire and its relationship to hypnotizability. Am J Clin Hypn 1989;32:17-26.
60. Kelly PJ. The relationship between hypnotic ability and hypnotic experience. Doctoral Dissertation. University of Waterloo. Waterloo, Ontario, Canada: 1985.
61. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomized controlled trials. BMJ 1999;319:670-4.
62. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum; 1988.
63. Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH. Two formulas for computation of area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003;28:916-31.
64. Domangue BB, Margolis CG, Lieberman D, Kaji H. Biochemical correlates of hypnoanalgesia in arthritic pain patients. J Clin Psychiatry 1985;46:235-8.
65. Zachariae R, Bjerring P, Zachariae C, etal. Monocyte chemotactic activity in sera after hypnotically induced emotional states. Scand J Immunol 1991;34:71-9.
66. Wood GJ, Tanavoli S, Bughi S, etal. Hypnosis, differential expression of cytokines by T-cell subsets, and the hypothalamic-pituitary-adrenal axis. Am J Clin Hypn 2003;45:179-96.
67. de Kloet ER. Hormones and the stressed brain. Ann N Y Acad Sci 2004;1018:1-15.
68. Tracey KJ. The inflammatory reflex. Nature 2002;420:853-9.
69. Clauw DJ, Chrousos G. Chronic pain and fatigue syndromes: Overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 1997;4:143-53.
70. Geiss A, Varadi E, Steinbach K, Bauer HW, Anton F. Psychoneuroimmunological correlates of persisting sciatic pain in patients who underwent discectomy. Neurosci Lett 1997;237(2-3):243-50.
71. Parker AJ, Wessely S, Cleare AJ. The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol Med 2001;31(8):1331-45.
72. Lisowska B, Maslinksi W, Maldyk P, Zabek J, Baranowska E. The role of cytokines in inflammatory response after total knee arthroplasty in patients with rheumatoid arthritis. Rheumatol Int 2008;28(7):667-71.
73. Prabhakar U, Eirikis E, Reddy M, etal. Validation and comparative analysis of a multiplexed assay for the simultaneous quantitative measurement of Th1/Th2 cytokines in human serum and human peripheral blood mononuclear cell culture supernatants. J Immunol Methods 2004;291:27-38.
74. Sachdeva N, Yoon HS, Oshima K, etal. Biochip array-based analysis of plasma cytokines in HIV patients with immunological and virological discordance. Scand J Immunol 2007;65:549-54.
75. Chou R, Hoyt Huffman L. Medications for acute and chronic low back pain: A review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med 2007;147(7):505-14.
76. Pinto-Ribeiro F, Moreira V, Pego JM, etal. Anti-nociception induced by chronic glucocorticoid treatment is correlated to local modulation of spinal neurotransmitter content. Mol Pain 2009;5(41):1-11.
77. Roelofs P, Deyo RA, Koes BW, Scholten RJ, van Tulder MW. Nonsteroidal anti-inflammatory drugs for low back pain: An updated Cochrane review. Spine 2008;33(16):1766-74.